Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Frank Weber, Dr.
Vivoryon Therapeutics N.V.
Study Director - Philip Scheltens, Prof. Dr.
VUmc Alzheimer Centre (p: +31 20 4440816)
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ziekenhuis Netwerk Antwerpen / Geheugenkliniek
Hoboken, Belgium
- Kliininen Tutkimuskeskus
Kuopio, Finland
- Oulu University Hospital
Oulu, Finland
- Crst Oy
Turku, Finland
- Chu Bordeaux Pellegrin (cmrr)
Bordeaux, France
- Chu François Mitterand (centre Mémoire Ressources Recherche (cmrr))
Dijon, France
- Chru de Lille / Hôpital Roger Salengro
Lille, France
- Hôpital la Grave / Centre de Recherche Clinique
Toulouse, France
- Charité - Universitätsmedizin Berlin
Berlin, Germany
- Universitätsmedizin Göttingen / Klinik Für Psychiatrie Und Psychotherapie
Göttingen, Germany
- Universitätsklinikum Halle (saale) Klinik Und Poliklinik Für Psychiatrie, Psychotherapie Und Psychosomatik
Halle, Germany
- Arzneimittelforschung Leipzig Gmbh
Leipzig, Germany
- Universitätsklinikum Magdeburg / Institut Für Kognitive Neurologie Und Demenzforschung
Magdeburg, Germany
- Klinikum Rechts Der Isar Der Tu München / Klinik Für Psychiatrie Und Psychotherapie
München, Germany
- Universitätsklinikum Münster / Klinik Für Allgemeine Neurologie
Münster, Germany
- Universitätsmedizin Rostock / Zentrum Für Nervenheilkunde/ Klinik Für Psychosomatik Und Psychotherapeutische Medizin
Rostock, Germany
- Neurologische Universitätsklinik Ulm
Ulm, Germany
- Alzheimer Research Center
Amsterdam, Netherlands
- Fundació Ace. Institut Català de Neurociències Aplicades
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau, Neurology Department, Memory Unit
Barcelona, Spain
- Complexo Hospitalario Universitario de Santiago (chus)
Santiago de Compostela, Spain
- Hospital Universitario Virgen Macarena
Seville, Spain
- Verksamheten För Neuropsykiatri Sahlgrenska Universitetssjukhuset
Mölndal, Sweden
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2015
- Primary completion
- 30 Apr 2017
- Completion
- 30 Apr 2017
- Last update posted
- 1 Jun 2017
- Registered enrollment
- 120
- Registry id
- NCT02389413
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.